“After progress in a second round of tests using stem cells to regrow nerve fibres, the China Spinal Cord Injury Network (ChinaSCINet) has applied for regulatory approval in China for a third and final phase, which it hopes to start in the autumn. 15 out of 20 patients in the Chinese city of Kunming, who received umbilical cord blood cell transplants and intensive walking therapy, were on average able to walk with minimal assistance seven years after complete spinal cord injury. The treatment involves injecting umbilical cord blood mononuclear cells into patients’ damaged spines to help regenerate nerves, while lithium is used to promote the growth of the nerve fibres.”
Related posts:
Iraq war killed 120,000 and cost $800 billion, study estimates
Fed Pulls QE3 Trigger; Will Buy Mortgages in Effort to Lower Rates
Amazon urged not to sell facial recognition tool to police
Some traders got Fed 'no taper' decision news early
Chicago police kill man with stun gun to break up group fight
No-fly zone at Obama family Colorado ski outing
Bitcoin Black Market Competition Heats Up, With Pro Marketing And Millions At Stake
American Airlines cutting 1,700 jobs in Tulsa, Fort Worth
Leaked Snowden documents: NSA hacked Chinese telecom company
US, Israel to hold major missile defense exercise
Iran claims U.S. Congress not ‘authorized’ to authorize Syria strikes
Gold Runs Out In Lisbon As Price Drop Compounds Money Misery
IKEA surges forward with store openings despite global economic turmoil
Walmart tells India it can’t buy enough local products for new supermarket
The Wealthy Are Hoarding $10 Billion of Bitcoin in Bunkers